메뉴 건너뛰기




Volumn 100, Issue 6, 2009, Pages 445-455

Oral contraceptives in dermatology;Contracepción hormonal oral en dermatología

Author keywords

Adverse effects; Androgenization; Congenital abnormalities; Indications; Noncontraceptive benefits.; Oral contraceptives

Indexed keywords

ANTICONVULSIVE AGENT; ASCORBIC ACID; BARBITURIC ACID DERIVATIVE; CHLORMADINONE ACETATE; CYPROTERONE ACETATE; DESOGESTREL; DISULFIRAM; DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETYNODIOL DIACETATE; GRISEOFULVIN; LEVONORGESTREL; LYNESTRENOL; MESTRANOL; MESTRANOL PLUS NORETYNODREL; NANDROLONE; NORETHISTERONE ACETATE; NORETYNODREL; NORGESTIMATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROGESTERONE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

EID: 67749088170     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(09)70100-3     Document Type: Review
Times cited : (3)

References (6)
  • 2
    • 4243333505 scopus 로고    scopus 로고
    • Grupo de trabajo sobre anticoncepción hormonal oral Zaragoza: Ed. Carlos Buil Rada
    • Grupo de trabajo sobre anticoncepción hormonal oral. Manual de anticoncepción hormonal oral. Zaragoza: Ed. Carlos Buil Rada; 1997.
    • (1997) Manual de Anticoncepción Hormonal Oral
  • 5
    • 33645747411 scopus 로고    scopus 로고
    • An overview of oral contraceptives: Mechanism of action and clinical use
    • C.A. Frye An overview of oral contraceptives: mechanism of action and clinical use Neurology 6 2006 29 36
    • (2006) Neurology , vol.6 , pp. 29-36
    • Frye, C.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.